Загрузка...
Lurasidone-induced anemia: Is there a need for hematological monitoring?
Lurasidone is a newer drug used for treating schizophrenia and depression in bipolar disorder. Although comparatively safe, some side effects can occur with its use such as akathisia, extrapyramidal reaction, metabolic syndrome, and hyperprolactinemia. Blood dyscrasia with lurasidone is rarely repor...
Сохранить в:
| Опубликовано в: : | Indian J Pharmacol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Wolters Kluwer - Medknow
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6759524/ https://ncbi.nlm.nih.gov/pubmed/31571715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijp.IJP_434_18 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|